Comparative Evaluation of Serum METRNL and CTRP3 Levels in Women with Polycystic Ovary Syndrome

Authors

  • Ghufran Saad Nsaif Department of Chemistry, College of Science, Baghdad University, Baghdad, Iraq. Author

DOI:

https://doi.org/10.70882/psxwmf83

Keywords:

Polycystic ovary syndrome; METRNL; CTRP3.

Abstract

Background: Meteorin-like protein (METRNL) and C1q/tumor necrosis factor-related protein 3 (CTRP3) are two fat tissue-related signal proteins which play a role in regulating the body's metabolism. Serum levels from METRNL and CTRP3 in women with polycystic ovary syndrome (PCOS) have been an area from study because of their potential relevance to both understanding the biology of PCOS as well as clinical implications. Purpose: To assess serum concentrations of METRNL and CTRP3 in PCOS-affected women compared to those without PCOS, and to evaluate several related metabolic and hemorheologic variables.

Methods: This case-control study was conducted from May to September of 2026. The study participants consisted of 34 women with PCOS and 34 age-matched healthy control subjects who were recruited from laboratory facilities in Baghdad, Iraq. A physician diagnosed PCOS after evaluating each patient's clinical presentation, as well as her hormone profile; this included assessing her total testosterone, free testosterone, sex hormone binding globulin (SHBG), luteinizing hormone (LH), follicle stimulating hormone (FSH), and prolactin (PRL) levels. In addition to hormone levels, the study evaluated participants' serum METRNL and CTRP3 levels, ages, BMI, HOMA-IR values, blood viscosities, and hematocrit percentages. To compare data between groups, researchers utilized appropriate statistical tests and adjusted for multiple comparisons using Holm's method. Spearman correlations and receiver operating characteristics (ROC) curves were generated to further explore possible relationships among variables.

 

Results: Serum METRNL and CTRP3 levels were found to be much lower in women who have PCOS than in control women (0.983 ± 0.188 vs. 1.858 ± 0.325 ng/mL and 1.841 ± 0.428 vs. 3.672 ± 0.605 ng/mL, respectively; both P < 0.001 after adjustment). Women with PCOS had considerably greater BMI, HOMA-IR, and blood viscosity than control women. However, hematocrit was not found to be significantly different. METRNL and CTRP3 did not correlate with HOMA-IR. There appeared to be a negative relationship between HOMA-IR and hematocrit.

Conclusion: Women with PCOS in this cohort showed a decrease in circulating levels of METRNL and CTRP3. The results of this study suggest that these two adipokines should be studied more to see if they are part of the biochemical phenotype associated with PCOS. The correlations found through exploratory analyses and discriminatory estimations based on samples will need to be verified using larger, independently characterized cohorts.

Downloads

Download data is not yet available.

Downloads

Published

2026-11-21

How to Cite

Comparative Evaluation of Serum METRNL and CTRP3 Levels in Women with Polycystic Ovary Syndrome. (2026). Journal of Pure and Applied Sciences (Science Forum), 26(5 (Special). https://doi.org/10.70882/psxwmf83

Similar Articles

You may also start an advanced similarity search for this article.